Tamsulosin HCL 0.4 MG capsule 1000S
Ended Awarded
- Contract number
- SPE2DB25FE1KH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,057
Award facts
- Contract value 100% obligated
- $4,056.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,056.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The order, which is scheduled for completion by September 29, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies a broad range of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. The company has demonstrated consistent capability in meeting federal procurement requirements through open competition, with a proven track record of fulfilling delivery orders encompassing medications across multiple therapeutic domains, including specialty pharmaceuticals, generic drugs, and medical supplies. This particular order for Tamsulosin HCL, a medication commonly used to treat benign prostatic hyperplasia, exemplifies the company's role in supporting military and veteran healthcare procurement through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DB25FE1KH?
SPE2DB25FE1KH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FE1KH worth?
The government has obligated $4,057 on SPE2DB25FE1KH.
Is contract SPE2DB25FE1KH an order under another contract?
Yes. SPE2DB25FE1KH is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1KH competed?
The extent of competition for SPE2DB25FE1KH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award